|
Proceedings
Day 3 - Thursday, September 28, 2000

ThOA
Is LC/TOF a Viable Bioanalytical Tool?
Discussion Leader: Timothy G. Heath, Pharmacia Corporation
While quadrupole based LC-MS/(MS) systems dominate the quantitative bioanalytical
arena, orthogonal time-of-flight (TOF) detection capable of fast acquisition rates and
accurate mass discrimination offer features which when coupled with HPLC, make it an
attractive bioanalytical tool. This session highlighted both the merits and current
limitations of LC-TOF (or Q-TOF) when utilized for bioanalysis.
LC/TOF for GLP
Liyu Yang, Schering-Plough
LC/TOF for Discovery
Scott Fountain, Pfizer Global R&D
High Throughput Protein Identification by Mass Spectrometry
Dominic Gostick, Micromass
Roundtable Discussion 10
ThOB
Data Management and Manipulation
Discussion Leader: John E. Coutant, Aventus Pharmaceuticals, Inc.
There has been a revolution in chemistry as combichem techniques and technologies have become
broadly adopted by synthetic chemistry groups, especially in the pharmaceutical industry. The
challenge of providing structural support for orders of magnitude increases in samples has
created a number of issues related to data acquisition, data management, data interpretation,
and data storage. This session explored some of these issues and approaches to meeting these
challenges.
Spectroscopy Management and Prediction Tools for the Screening of Combinatorial Library Analytical Data
Antony Williams, Advanced Chemistry Development
Information Solutions for High Throughput LC/MS Purity and Structure Determination in Drug Discovery
John E. Coutant and Jeffery L. Dage, Aventis Pharmaceuticals Inc., Bridgewater, NJ
Roundtable Discussion 11
ThOC
Drugability High Throughput Screening: In Vitro Methods
Discussion Leader: Alex Avdeef, pION
Screening and Analytical Measurements of the Relative Hydrophobicity and Lipophilicity of Chemical
Compounds for Drug Discovery
Boris Zaslavsky, Analiza, Inc.
High-Throughput Measurements of Lipophilicity for Lead Optimization Using RP-HPLC
Chau Du, Glaxo Wellcome
High-Throughput Screening Method for Measurement of the Phospholipid Membrane Permeability, Aqueous
Solubility and Membrane Retention of Molecules
Konstantin Tsinman, pION Inc.
LC/MS-Based LogP Method
Robyn A. Rourick, DuPont, Pharmaceutical Research Laboratories
High-Throughput Stability Assessments
Edward H. Kerns, Wyeth-Ayerst Research
High-Throughput pKa
Karl Box, Sirius Analytical Instruments
Roundtable Discussion 12
ThOD:
New Technologies and Future Trends for High Throughput
Discussion Leader: Honggang Bi, Parke-Davis Pharmaceutical Research
The world is changing around high throughput analysis. LC/MS and related technologies had their
prime time in 1990's. They have revolutionized the way we perform pharmaceutical analysis. In
this session, we looked at new ways to improve our efficiency and productivity in analytical
laboratories. "Lab-on-a-chip" is certainly starting to show its potential in drug discovery
and it will bring us another revolution in the near future. In the meantime, scientists are
thinking creatively and figuring out new ways to improve LC/MS productivity using various new
hardware and software. Automation in every aspect of LC/MS bioanalysis will change our laboratories
dramatically.
Miniaturized, Integrated and Automated Pharmaceutical Discovery Experimentation With Lab-on-a-Chip Systems
Michael L. Nedved, Centocor
Caught in a Parallel World: Stretching the Boundaries of Bioanalytical Mass Spectrometry
Mark Cole, Pfizer, Inc.
Roundtable Discussion 13
|